Response to Williams' comment
نویسندگان
چکیده
منابع مشابه
A Response to Mooi, Williams and Gill
EDWARD O. WILEY, PROSANTA CHAKRABARTY, MATTHEW T. CRAIG, MATTHEW P. DAVIS, NANCY I. HOLCROFT, RICHARD L. MAYDEN & WM. LEO SMITH Department of Ecology and Evolutionary Biology and Biodiversity Research Center, University of Kansas, Lawrence, KS, U.S.A. E-mail: [email protected] Museum of Natural Science, Louisiana State University, Baton Rouge, LA, U.S.A. E-mails: [email protected] (PC), matthewdavis...
متن کاملComment on Williams and Farmer's evaluation of daytime running lights.
In ‘Comments on Theeuwes and Riemersma’s Revisit of Daytime Running Lights’ Williams and Farmer ( 1996) comment on a paper we published in Accident Analysis and Prevention. In this paper we show that the original claim by Andersson and Nilsson ( 198 1) that the nationwide implementation of Daytime Running Lights (DRL) in Sweden resulted in a reduction of multiple daytime accidents was not warra...
متن کاملTo infer or not to infer? A comment on Williams and Bornmann
Since the beginning of the twentieth century, statistics has completely revolutionized the manner in which scientific esearch is performed. Statistical techniques emerged based on the intrinsic random nature of the data and, equally imporant, on the scarce data availability. The techniques were both mathematically challenging and computationally intensive. hile the computation issue for various...
متن کاملAmygdala response to faces parallels social behavior in Williams syndrome.
Individuals with Williams syndrome (WS), a genetically determined disorder, show relatively strong face-processing abilities despite poor visuospatial skills and depressed intellectual function. Interestingly, beginning early in childhood they also show an unusually high level of interest in face-to-face social interaction. We employed functional magnetic resonance imaging (fMRI) to investigate...
متن کاملResponse to comment by Moxon et al.
We would like to thank Clinical Science for the opportunity to respond to the letter [1] which suggests that while we have been able to show that PTP1B inhibitor, trodusquemine, decreases atherosclerotic plaque size as well as serum triglycerides and cholesterol, that we have not shown that it reverses the plaque size, using in vivo imaging techniques such as MRI scanning or ultrasound. Both Ld...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Science Education
سال: 1994
ISSN: 0036-8326,1098-237X
DOI: 10.1002/sce.3730780507